| |
|
|
|
PLx Pharma Inc.  
|
|
5.49 0.16 (0.03%) |
04-18 16:00 |
|
Open: |
5.446 |
Pre close: |
5.33 |
Target:
|
6.73 
|
|
High: |
5.4995 |
Low: |
5.4995 |
Resistance:
|
5.76
6.23
|
|
Volume: |
4,224 |
Market Cap: |
48M |
Support:
|
5.00
4.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.37
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
5.41 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
4.53 |
Stochastic Oscillator |
%K(14,3):
|
64.30 |
|
MA(250): |
4.17 |
%D(3): |
54.86 |
|
Average Volume(K) |
3-Month: |
1961
|
52-Week |
High:
|
6.44 |
|
10-Days: |
515 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
52.34 |
Change(%): |
30.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.400 |
Return on Equity (ttm) |
16.2 |
Shares Out. (M) |
8.75 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
3.8 |
Shares Float (M) |
4.28 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.09 |
% Held by Insiders |
51.20 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
-15.5 |
% Held by Institutions |
26.40 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
7.450 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.50 |
P/S |
533749952.00 |
|
Operating Margin |
-1455.46 |
Levered Free Cash Flow
(M) |
-6.50 |
P/CF |
-5.06 |
|
|
|
|
|
|
